Moderna, Inc.

NASDAQ-GS: MRNA

,USD

+1,99 (3,97%)↑ today

Price at Apr 8, 4:00:01 PM EDT • Market Closed

Is it expensive?

Trailing P/E Ratio

Explainer

Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

Ratio PER: La cara cara de las acciones baratas

24,97

Forward P/E Ratio

Explainer

Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

Ratio PER: La cara cara de las acciones baratas

-10,61

PEG Ratio

Explainer

PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

Ratio PEG: el mejor amigo de los que buscan crecimiento

-0,91

Enterprise Value to EBITDA

-5,17

Price-to-Sales (TTM)

Explainer

Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

Ratio precio-ventas (P/S): Identifica el crecimiento antes que nadie

10,05

Price-to-Book (MRQ)

2,24

Book Value per Share (MRQ)

21,95

Market Cap

Explainer

Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

Capitalización bursátil: a veces, el tamaño sí importa

19,87B

Enterprise Value

14,77B

Is it profitable?

Net Profit Margin (TTM)

Explainer

Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

-145,16%

Gross Profit Margin

Explainer

Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

33,14%

Diluted EPS (TTM)

Explainer

Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

Beneficio por acción (BPA): la métrica que revela más que los titulares sobre beneficios

-7,26

Return on Equity (TTM)

-28,87%

Revenue (TTM)

1,94B

Is it growing?

Revenue Growth (MRQ)

-29,80%

Earnings Growth (YOY)

-29,29%

Is it risky?

Beta

1,34

Debt to Equity (MRQ)

15,09

Current Ratio (MRQ)

3,29

Total Debt (MRQ)

1,30B

Who owns it?

Institutional Ownership

77,13%

Insider Ownership

7,32%

Short Interest

20,42%

Shares Outstanding

394,00M

Shares Float

368,43M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

Dividend Date

How much cash?

Total Cash (MRQ)

5,80B

Operating Cash Flow (TTM)

-1,87B

Levered Free Cash Flow (TTM)

-1,33B

Total Cash per Share (MRQ)

14,68

Indicators

Founder-operated companies generally perform better.

Founders

Noubar Afeyan, Robert S. Langer, Timothy A. Springer, Kenneth R. Chien, Derrick J. Rossi

CEO

Stéphane Bancel

Biotechnology

Operating Cash Flow

-1,87B

÷0

Net Income

-2,82B

Mixed Signal

0.66

Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Indicators

Founder-operated companies generally perform better.

Founders

Noubar Afeyan, Robert S. Langer, Timothy A. Springer, Kenneth R. Chien, Derrick J. Rossi

CEO

Stéphane Bancel

Biotechnology

Operating Cash Flow

-1,87B

÷0

Net Income

-2,82B

Mixed Signal

0.66

Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Is it expensive?

Trailing P/E Ratio

Explainer

Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

Ratio PER: La cara cara de las acciones baratas

24,97

Forward P/E Ratio

Explainer

Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

Ratio PER: La cara cara de las acciones baratas

-10,61

PEG Ratio

Explainer

PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

Ratio PEG: el mejor amigo de los que buscan crecimiento

-0,91

Enterprise Value to EBITDA

-5,17

Price-to-Sales (TTM)

Explainer

Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

Ratio precio-ventas (P/S): Identifica el crecimiento antes que nadie

10,05

Price-to-Book (MRQ)

2,24

Book Value per Share (MRQ)

21,95

Market Cap

Explainer

Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

Capitalización bursátil: a veces, el tamaño sí importa

19,87B

Enterprise Value

14,77B

Is it profitable?

Net Profit Margin (TTM)

Explainer

Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

-145,16%

Gross Profit Margin

Explainer

Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

33,14%

Diluted EPS (TTM)

Explainer

Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

Beneficio por acción (BPA): la métrica que revela más que los titulares sobre beneficios

-7,26

Return on Equity (TTM)

-28,87%

Revenue (TTM)

1,94B

Is it growing?

Revenue Growth (MRQ)

-29,80%

Earnings Growth (YOY)

-29,29%

Is it risky?

Beta

1,34

Debt to Equity (MRQ)

15,09

Current Ratio (MRQ)

3,29

Total Debt (MRQ)

1,30B

Who owns it?

Institutional Ownership

77,13%

Insider Ownership

7,32%

Short Interest

20,42%

Shares Outstanding

394,00M

Shares Float

368,43M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

Dividend Date

How much cash?

Total Cash (MRQ)

5,80B

Operating Cash Flow (TTM)

-1,87B

Levered Free Cash Flow (TTM)

-1,33B

Total Cash per Share (MRQ)

14,68

Moderna, Inc.

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Regulatory Identifiers

Indicators

Indicators

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Regulatory Identifiers

Moderna, Inc.

Stock Details

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Regulatory Identifiers

Indicators

Indicators

Stock Details

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Regulatory Identifiers